Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReJoin Phase IIb for Knee Osteoarthritis
NCT02162693Phase 2Completed
- Sponsor
- AbelZeta
- Start
- Nov 2013
- Primary completion
- May 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogenic adipose tissue-derived mesenchymal progenitor cells in knee osteoarthritis (OA), sponsored by AbelZeta. Started Nov 2013; status: completed.
02
Drugs
allogenic adipose tissue-derived mesenchymal progenitor cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02162693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02162693.